THE BEHAVIOR OF I131-LABELED PLASMA PROTEINS IN VIVO-Reference-Cited by-同舟云学术

THE BEHAVIOR OF I131-LABELED PLASMA PROTEINS IN VIVO

Published:2006-12-15 Issue:1 Volume:70 Page:19-25
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

McFarlane A. S.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1957.tb35374.x/fullpdf

Reference17 articles.

1. Labelling of plasma proteins with radioactive iodine;McFarlane;Biochem. J.,1956

2. Distribution and elimination of 131-I- and 14-C-labelled plasma proteins in the rabbit;Cohen;Biochem. J.,1956

3. Behaviour of 14-C- and 131-I-labelled plasma proteins in the rat;Campbell;Intern. J. Appl. Radiation and Isotopes,1956b

4. Dovey , A. R. C. Holloway R. S. Piha J. H. Humphrey A. S. McFarlane 1954 Preparation and some uses of high specific activity plasma proteins Proc. 2nd Radioisotope Conf. Oxford. 1954 337 345

5. Antigen elimination from blood as early manifestation of immune response;Talmage;J. Immunol.,1951

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles;Histochemistry and Cell Biology;2020-10-11

2. Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis;Frontiers in Immunology;2020-01-10

3. Early De-risking Strategy for Novel Biotherapeutics;Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics;2013

4. A pharmacokinetic model for the glycation of albumin;Journal of Pharmacokinetics and Pharmacodynamics;2012-04-21

5. Pharmacokinetic Models for FcRn-Mediated IgG Disposition;Journal of Biomedicine and Biotechnology;2012